Skip to content
Screener

EBITDA at other companies

AptarGroup logo
AptarGroupATR
$171.81M-4.1%
AVT
AvantorAVTR
$227.4M-1.8%
Dow logo
DowDOW
$1.75B+537%
DuPont de Nemours, Inc. logo
DuPont de Nemours, Inc.DD
$376M+10.6%
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
Halozyme Therapeutics logo
Halozyme TherapeuticsHALO

Other financials

Income statement

See full
Revenue$872.3M+13.8%
Gross profit$329.2M+20.2%
Operating income$179.1M+16.5%
Net income$154.0M+16.8%
EPS (diluted)$2.15+18.1%

Balance sheet

See full
Cash & equivalents$435.8M-14.5%
Total debt$316.5M+2.7%
Total equity$3.0B+2.1%
Total assets$4.1B+3.1%

Cash flow

See full
Operating cash flow$124.0M-30.0%
CapEx$43.2M-42.6%
Free cash flow$80.8M-20.7%

Valuation

See full
Market cap$24B+40.0%
Enterprise value$23.88B+40.9%
P/E42.5×+7.3×
P/S7.2×+1.4×

Profitability

See full
Gross margin36.8%+1.5pp
Operating margin20.5%+0.8pp
Net margin17%+0.5pp
FCF margin13.1%+1.5pp

Returns & leverage

See full
Return on equity19.1%+1.4pp
Debt / equity0.1×0.0×
Current ratio2.8×0.0×

Where this comes from

Calculated from West Pharmaceutical Services’s reported figures.

$179.1Mebit+
$46.2MDepreciation Depletion & Amortization
=$225.3M

The source filing: West Pharmaceutical Services’s 10-Q, filed July 23, 2026. Open the filing →

Filed
Jul 23, 2026, 4:15 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000105770-26-000099

FAQ

What is West Pharmaceutical Services's EBITDA?
West Pharmaceutical Services (WST) reported EBITDA of $225.3M in Q2 2026.
How has West Pharmaceutical Services's EBITDA changed year-over-year?
West Pharmaceutical Services's EBITDA increased by 15.5% year-over-year, from $195.1M to $225.3M.
What is the long-term trend for West Pharmaceutical Services's EBITDA?
Over 4 years (2021 to 2025), West Pharmaceutical Services's EBITDA has grown at a -3.4% compound annual growth rate (CAGR), from $869.4M to $755.7M.
What does EBITDA mean?
Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.

Ask your AI about West Pharmaceutical Services's ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude